Latest News Archive
Please select Category, Year, and then Month to display items
16 February 2024
|
Story ANTHONY MTHEMBU
|
Photo ROSINA MOTHIBA
Prof Matseliso Mokhele-Makgalwa: Vice Dean; Research, Engagement and Internationalisation in the Faculty of Education at the University of the Free State (UFS).
The Faculty of Education at the University of the Free State (UFS) proudly announces the appointment of Prof Matseliso Mokhele-Makgalwa as Vice Dean of Research, Engagement and Internationalisation, effective 1 January 2024. With a wealth of experience and a fervent dedication to academic advancement, Prof Mokhele-Makgalwa’s appointment marks a significant stride towards enhancing the faculty’s global presence and academic prowess.
Transitioning into a new role
Transitioning seamlessly from her previous role as Acting Vice Dean of Research and Postgraduate Studies, Prof Mokhele-Makgalwa perceives this new appointment as a natural progression, elevating her responsibilities to spearhead research endeavours, foster engagement, and cultivate international partnerships within the faculty. Embracing this pivotal role with enthusiasm, she underscores the importance of collaborative efforts among faculty members, securing research funding, and ensuring the quality and impact of scholarly outputs.
“I appreciate the opportunity to contribute significantly to the faculty’s research, engagement and internalisation efforts,” says Prof Mokhele-Makgalwa. “I look forward to collaborating with the faculty staff members to advance our academic initiatives on a broader scale.”
A vision of progression for the faculty
At the heart of her vision lies a commitment to realise the UFS’s Vision130, wherein Prof Mokhele-Makgalwa aims to elevate the international profile of the faculty, foster impactful research, promote engaged scholarship, and facilitate knowledge exchange on a global scale. Her strategic objectives also include positioning the faculty among the top three education schools nationally, reflecting her dedication to academic excellence and institutional advancement.
UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08
The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.
The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.
The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.
“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.
“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.
According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.
The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.
According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.
The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.
Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004